Cornelis Scott 4
4 · Enova International, Inc. · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Enova (ENVA) CFO Cornelis Scott Receives Equity Awards
What Happened
- Cornelis Scott, Chief Financial Officer of Enova International, received two equity awards on February 11, 2026: 3,276 restricted stock units (RSUs) and 2,105 derivative awards (a limited stock appreciation right (SAR) granted in tandem with an employee stock option). Both grants were reported as acquisitions at $0.00 (no cash paid).
Key Details
- Transaction date: February 11, 2026; Form 4 filed Feb 13, 2026 (timely filing).
- Award amounts: 3,276 RSUs (grant) and 2,105 SAR/option units (derivative grant). Reported acquisition price: $0.00.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnotes of note:
- RSU vesting (F1): vests in four substantially equal annual installments on Feb 11 of 2027, 2028, 2029 and 2030, contingent on continued employment.
- SAR/option tandem (F2–F4): the SAR and option were granted together—exercising one cancels the other. The SAR can be exercised only after a "Change in Control" and only during a 30-day window following that event; payout depends on the 30-day average selling price ("Offer Value Per Share") and applies only if an "Offer" (as defined) occurs. The underlying options vest in three substantially equal annual installments on Feb 11 of 2027, 2028 and 2029.
- Filing timeliness: Transaction date Feb 11, 2026; Form 4 filed Feb 13, 2026 — within the typical two-business-day reporting window.
Context
- These are grants/awards (code A) rather than open-market purchases or sales; they represent compensation/retention incentives and do not by themselves indicate immediate buying or selling in the market.
- The SAR/option structure ties potential value to a change-in-control or qualifying offer, so any payout depends on future corporate events and vesting conditions.
Insider Transaction Report
Form 4
Cornelis Scott
Chief Financial Officer
Transactions
- Award
Common stock, par value $0.00001 per share
[F1]2026-02-11+3,276→ 11,091 total - Award
Non-Qualified Stock Option (right to buy) with limited SAR
[F2][F3][F4]2026-02-11+2,105→ 2,105 totalExercise: $157.79Exp: 2033-02-11→ Common stock; par value $0.00001 per share (2,105 underlying)
Footnotes (4)
- [F1]This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030.
- [F2]The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- [F3]The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- [F4]The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029.
Signature
/s/ Sean Rahilly, as attorney in fact|2026-02-13